Mesenchymal Stem Cells Reduce Left Ventricular Mass in Rats with Doxorubicin-Induced Cardiomyopathy
SUMMARY: Doxorubicin is a drug that used by a majority in the treatment of carcinomas. The most obvious known side effect is cardiomyopathy. Many studies have been carried out to eliminate side effects of the doxorubicin, and stem cell studies have been added in recent years. In this study, it was a...
Guardado en:
Autores principales: | Haydardedeoglu,Ali Evren, Boztok Özgermen,Deva Basak, Yavuz,Orhan |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad Chilena de Anatomía
2018
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022018000100048 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Differential effects of doxorubicin on atrial natriuretic peptide expression in vivo and in vitro
por: RAHMAN,ASIM, et al.
Publicado: (2001) -
Stem cells: sources and therapies
por: Monti,Manuela, et al.
Publicado: (2012) -
The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells
por: Alexander Keller, et al.
Publicado: (2021) -
Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles
por: Yamoah MA, et al.
Publicado: (2018) -
A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriers
por: Robert E. Rogers, et al.
Publicado: (2021)